Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Revolution Medicines (RVMD) Amortizatization of Intangibles: 2018-2024

Historic Amortizatization of Intangibles for Revolution Medicines (RVMD) over the last 7 years, with Dec 2024 value amounting to $44.6 million.

  • Revolution Medicines' Amortizatization of Intangibles changed negligibly% to $300,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $19.2 million, marking a year-over-year decrease of 21.38%. This contributed to the annual value of $44.6 million for FY2024, which is 100.70% up from last year.
  • Latest data reveals that Revolution Medicines reported Amortizatization of Intangibles of $44.6 million as of FY2024, which was up 100.70% from $22.2 million recorded in FY2023.
  • In the past 5 years, Revolution Medicines' Amortizatization of Intangibles registered a high of $44.6 million during FY2024, and its lowest value of $2.9 million during FY2020.
  • In the last 3 years, Revolution Medicines' Amortizatization of Intangibles had a median value of $22.2 million in 2023 and averaged $23.8 million.
  • Data for Revolution Medicines' Amortizatization of Intangibles shows a peak YoY skyrocketed of 381.15% (in 2023) over the last 5 years.
  • Revolution Medicines' Amortizatization of Intangibles (Yearly) stood at $2.9 million in 2020, then rose by 10.96% to $3.2 million in 2021, then skyrocketed by 45.13% to $4.6 million in 2022, then spiked by 381.15% to $22.2 million in 2023, then surged by 100.70% to $44.6 million in 2024.